Modeling Neuropsychiatric Disorders in Young Mice with 90CGG Fragile X Premutation
Overview
This study utilized a doxycycline-inducible 90CGG mouse model to investigate early neuropsychiatric features associated with the fragile X premutation. Findings revealed a progression from adolescent hyperactivity to adult anxiety, linked to intranuclear inclusions, altered gamma oscillations, and reduced parvalbumin interneurons in limbic regions, with molecular changes paralleling behavioral phenotypes.
Background
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder caused by a CGG repeat expansion in the FMR1 gene. Premutation carriers often exhibit neuropsychiatric symptoms such as anxiety, ADHD, and depression before FXTAS onset, collectively termed fragile X-associated neuropsychiatric disorders (FXAND). Rodent models have demonstrated motor impairments and anxiety, but early neuropsychiatric mechanisms remain unclear. This study focuses on early developmental stages to elucidate behavioral, electrophysiological, and molecular changes in premutation carriers.
Data Highlights
Parameter
Adolescence
Young Adulthood
Behavioral Phenotype
Hyperactivity
Heightened Anxiety
Intranuclear Inclusions
Accumulation in BLA and vH
Increased accumulation in BLA and vH
Gamma Oscillations (vH)
Augmented
Persistently Augmented
Parvalbumin Interneurons
Reduced
Reduced
Proteomic Changes
ADHD-linked proteins altered
Anxiety/depression-linked proteins altered
Reversibility
Behavioral and cellular changes reversible upon transgene inactivation
Same as adolescence
Key Findings
Adolescent 90CGG mice exhibit early hyperactivity transitioning to anxiety in young adulthood.
Intranuclear inclusions accumulate progressively in the basolateral amygdala and ventral hippocampus.
Electrophysiological recordings show increased gamma oscillations in the ventral hippocampus starting in adolescence.
Reduction of parvalbumin-positive interneurons correlates with altered limbic network excitability and plasticity.
Proteomic analyses reveal molecular pathways linked to ADHD in adolescence and anxiety/depression in adulthood.
Behavioral, electrophysiological, and cellular abnormalities are reversible upon transgene deactivation.
Clinical Implications
These findings highlight a temporal progression of neuropsychiatric symptoms in fragile X premutation carriers, emphasizing the importance of early detection and intervention. The reversibility of phenotypes upon transgene inactivation suggests potential therapeutic windows targeting molecular and network dysfunctions in limbic circuits. Understanding altered gamma oscillations and interneuron deficits may guide development of treatments for FXAND symptoms.
Conclusion
The 90CGG mouse model reveals a developmental trajectory from hyperactivity to anxiety linked to limbic system alterations, providing mechanistic insights into fragile X-associated neuropsychiatric disorders. These results underscore the potential for early therapeutic strategies to mitigate neuropsychiatric manifestations in premutation carriers.
Burnout is easing. Sleep science is getting weird. And dental schools have been winging cadaver training for 50 years. This week's research is full of good news that immediately complicates itself.
